We performed clinical verification of MME, one of the tumor-associated proteins with significantly high fold changes in proteomics data, in individual plasma samples from controls and early stage GBC cases and found significantly increased levels in early stage GBC cases (Fig. 3F). This evidence concerns the gene MME and neoplasm.